STIPULATION AND ORDER RE LEAVE TO FILE AMENDED JOINT PROPOSED JURY INSTRUCTIONS

HAYWOOD S. GILLIAM, JR., District Judge.

Pursuant to Civil L.R. 7-12, Plaintiff Plexxikon Inc. ("Plexxikon") and Defendant Novartis Pharmaceuticals Corporation ("Novartis") (collectively, "the parties") hereby jointly request that the Court grant leave to file the attached Amended Joint Jury Instructions (Ex. A).

I. FACTS

The parties first filed Joint Proposed Jury Instructions on October 18, 2019. (ECF No. 309). The Court held a case management conference on December 3, 2019, at which it directed the parties "to meet and confer regarding substantive jury instructions and e-file by December 20th a revised set of complete jury instructions." ECF Nos. 347; see also ECF No. 352 at 10:12-19, 12:11. Pursuant to that order, the parties filed a revised set of complete jury instructions on December 20, 2019. (ECF No. 357).

On December 23, 2019, Plexxikon revised its proposal for Disputed Final Instruction No. 27. Thereafter, the parties exchanged revised one-page position statements. Plexxikon's revised proposal and the parties' updated position statements are incorporated in the attached Amended Joint Proposed Jury Instructions (Exhibit A), which the parties seek leave to file.

The Court has set March 25, 2020 for a hearing on jury instructions. ECF No. 347.

II. DISCUSSION

Good cause exists for the Court to grant leave because the proposed changes to the current Joint Proposed Jury Instructions (ECF No. 357) reflect the parties' continued work to resolve disputes regarding the jury instructions. Accordingly, the parties respectfully request that they be permitted to file the attached Amended Joint Jury Instructions (Ex. A).

PURSUANT TO STIPULATION, IT IS SO ORDERED.